A CASE REPORT OF A PATIENT WITH FOUR METACHRONOUS CANCERS
Abstract
Multiple primary malignant neoplasms (MPMNs) are two or more histopathologically distinct malignancies in one or more organs such that one tumor is not a recurrence or metastasis of the other. Although there are well-known genes associated with hereditary cancers, sometimes it is not possible to find a genetic link between neoplasms. Our patient had four metachronous primary malignancies: breast cancer (BC), rectal cancer (RC), parotid cancer, lung cancer (LC), and highly suspected contralateral BC, over a 28-year period. We presented the challenges in diagnosis and therapeutic approach and highlighted the importance of genetic counseling and testing in these patients. To achieve better treatment, we need to find out which patients are at risk for MPMNs, and which tumors are more likely to occur synchronously or metachronously and enroll these patients in clinical trials.
References
Babacan NA, Aksoy S, Cetin B, Ozdemir NY, Benekli M, Uyeturk U, et al. Multiple primary malignant neoplasms: multi-center results from Turkey. J BUON 2012;17(4):770-5.[PubMed]
Chan GHJ, Ong PY, Low JJH, Kong HL, Ow SGW, Tan DSP, et al. Clinical genetic testing outcome with multi-gene panel in Asian patients with multiple primary cancers. Oncotarget 2018;9(55):30649-60. [CrossRef] [PubMed]
Cybulski C, Nazarali S, Narod SA. Multiple primary cancers as a guide to heritability. Int J Cancer 2014;135(8):1756-63. [CrossRef] [PubMed]
De Luca A, Frusone F, Vergine M, Cocchiara R, La Torre G, Ballesio L, et al. Breast Cancer and Multiple Primary Malignant Tumors: Case Report and Review of the Literature. In Vivo 2019;33(4):1313-24. [CrossRef] [PubMed]
Halamkova, J, Kazda T, Pehalova L, Gonec R, Kozakova S, Bohovicova L, et al. Second primary malignancies in colorectal cancer patients. Sci Rep 2021;11(1):2759. [CrossRef] [PubMed]
Ibrahim ME, Saleh M, Ali A, Alavi N. Multiple Primary Malignant Neoplasms: An Unusual Case of Metachronous Breast Ductal and Squamous Cell Carcinomas. Cureus 2020;12(2):e6954. [CrossRef] [PubMed]
LaDuca H, Polley EC, Yussuf A, Hoang L, Gutierrez S, Hart SN, et al. A clinical guide to hereditary cancer panel testing criteria in a cohort of 165,000 high-risk patients. Genet Med 2020;22(2):407-15. [CrossRef] [PubMed]
Nyqvist J, Kovács A, Einbeigi Z, Karlsson P, Forssell-Aronsson, E, Helou K, et al. Genetic alterations associated with multiple primary malignancies. Cancer Med 2021;10(13):4465-77. [CrossRef] [PubMed]
Vaittinen P, Hemminki K. Risk factors and age-incidence relationships for contralateral breast cancer. Int J Cancer 2000;88(6):998-1002. [CrossRef] [PubMed]
Vogt A, Schmid S, Heinimann K, Frick H, Herrmann C, Cerny T, et al. Multiple primary tumours: challenges and approaches, a review. ESMO Open 2017;2(2):e000172. [CrossRef] [PubMed]
